QuikPath

QuikPath was a Singapore-based diagnostics and medical device company focused on rapid, portable infectious disease testing. The company developed an isothermal RT-PCR and microfluidic cartridge platform intended to deliver accurate point-of-care or home-based molecular diagnostics without complex laboratory infrastructure. Its lead product, QScreen for COVID-19, was positioned as a low-cost, visually read rapid PCR-style test for SARS-CoV-2 and was described as the first indigenously developed diagnostic solution of its class registered in Singapore. Publicly available sources indicate the company was founded around 2019 and remained a small private venture, but a recent Singapore corporate-status source indicates the legal entity has been struck off. Based on available information, QuikPath appears to have been a diagnostics platform company rather than a therapeutics developer.